8-K filed October 28, 2024, 7:59 PM ET ticker OSTX CIK 0001795091

leadership confidence high sentiment positive materiality 0.55

OS Therapies appoints two new independent directors; Chairman Goddard and Joacim Borg resign

OS Therapies Inc

Colin Goddard (Chairman) and Joacim Borg resigned effective Oct 28, 2024; no disagreement with company operations.
Avril McKean Dieser appointed independent director; VP, Head Legal Patient Evidence at UCB; regulatory/commercialization expertise.
Olivier R. Jarry appointed independent director; co-founder/CEO of Libera Bio; 40+ years biopharma experience.
Company preparing for FDA discussion on pivotal trial of OST-HER2 for osteosarcoma; building infrastructure for potential commercial launch.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Colin Goddard

Chairman of the Board and director

OSTX · OS Therapies Inc

Effective: 2024-10-28
Filed: October 28, 2024, 7:59 PM ET

Effective October 28, 2024, Colin Goddard, Ph.D. notified the Board of Directors (the “Board”) of the Company of his resignation as the Chairman of the Board and director of the Company, effective immediately.

Departed

Joacim Borg

director

OSTX · OS Therapies Inc

Effective: 2024-10-28
Filed: October 28, 2024, 7:59 PM ET

Also, effective October 28, 2024, Joacim Borg notified the Board of his resignation as a director, effective immediately.

Appointed

Avril McKean Dieser

director

OSTX · OS Therapies Inc

Effective: 2024-10-28
Filed: October 28, 2024, 7:59 PM ET

Avril McKean Dieser and Olivier R. Jarry joined the Board, effective October 28, 2024.

Appointed

Olivier R. Jarry

director

OSTX · OS Therapies Inc

Effective: 2024-10-28
Filed: October 28, 2024, 7:59 PM ET

Avril McKean Dieser and Olivier R. Jarry joined the Board, effective October 28, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Colin Goddard resigned as Chairman of the Board and director at OS Therapies Inc.

Action: resigned
Role: Chairman of the Board and director

Exact text from the filing

Effective October 28, 2024, Colin Goddard, Ph.D. notified the Board of Directors (the “Board”) of the Company of his resignation as the Chairman of the Board and director of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joacim Borg resigned as director at OS Therapies Inc.

Action: resigned
Role: director

Exact text from the filing

Also, effective October 28, 2024, Joacim Borg notified the Board of his resignation as a director, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Avril McKean Dieser was appointed as director at OS Therapies Inc.

Action: appointed
Role: director

Exact text from the filing

Avril McKean Dieser and Olivier R. Jarry joined the Board, effective October 28, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Olivier R. Jarry was appointed as director at OS Therapies Inc.

Action: appointed
Role: director

Exact text from the filing

Avril McKean Dieser and Olivier R. Jarry joined the Board, effective October 28, 2024.

View on SEC.gov

OS Therapies Inc filing history →

Source: SEC EDGAR

accession 0001213900-24-091235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.